AstriVax

Heverlee, Belgium

AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.

$3.2M raised

Dec 2023

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has AstriVax raised?

AstriVax has raised $3.2M in total funding. The most recent round was Grant. The last funding was announced in December 2023.

Who are AstriVax's investors?

AstriVax's investors include Mérieux Equity Partners, V-Bio Ventures, Thuja Capital, Gemma Frisius Fund, Fund+.

Where is AstriVax headquartered?

AstriVax is headquartered in Heverlee, Belgium.

What does AstriVax do?

AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.

What stage is AstriVax at?

AstriVax is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 12, 2023.

MLA

"AstriVax — Funding & Investors." VCBacked, December 12, 2023, https://www.vcbacked.co/company/astrivax. Accessed July 1, 2026.

APA

VCBacked. (2023). AstriVax — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/astrivax

Wikipedia (cite web)

{{cite web |title=AstriVax — Funding & Investors |url=https://www.vcbacked.co/company/astrivax |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 12, 2023.